Formulation and characterization of levofloxacin-loaded biodegradable nanoparticles

Main Article Content

Hitesh B Gevariya
Suresh Gami
Nitin Patel


Effective management of various ocular infective diseases using levofloxacin eye drops remains challenging owing to poor ocular drug bioavailability. Hence, this study aimed to develop and evaluate nanosphere colloidal suspension-containing
levofloxacin as potential ophthalmic drug delivery system.The levofloxacin-loaded chitosan nanoparticles were prepared by ionic gelation of chitosan with tripolyphosphate anions.The nanoparticles were characterized by scanning electron microscopy, zeta potential analyzer, differential scanning calorimetry, and fourier transform infrared spectroscopy. All the prepared formulations resulted in nano-range size particles (317–501 nm) and displayed spherical smooth morphology with zeta potential (+37.2 to +43.5 mV).The encapsulation efficiency and loading capacity were 65–83% and 15–25%, respectively. The levofloxacin-loaded chitosan nanoparticles displayed more crystallinity than levofloxacin. The in vitro diffusion profile of levofloxacin from the nanoparticles showed a sustained release of the drug over a period of 20 h. Kinetic release profiles of levofloxacin from nanoparticles appeared to fit best with Higuchi model with zero order and the non-Fickian diffusion was superior phenomenon. Thus, the results suggest that levofloxacin-loaded chitosan nanoparticle suspension appears to
be promising enough for effective management of ocular infections.


Download data is not yet available.

Article Details

How to Cite
Gevariya, H. B., Gami, S., & Patel, N. (2014). Formulation and characterization of levofloxacin-loaded biodegradable nanoparticles. Asian Journal of Pharmaceutics (AJP), 5(2).


Knapczyk J, Kro Ìwczynski L, Krzck J, Brzeski M, Nirnberg E, Schenk

D, et al. Requirements of chitosan for pharmaceutical and biomedical

applications. In: Skak-Braek G, Anthonsen T, Sandford P, editors. Chitin

and Chitosan: Sources, Chemistry, Biochemistry, Physical Properties

and Applications. London: Elsevier; 1989. p. 657-63

Artursson P, Lindmark T, Davis SS, Illum L. Effect of chitosan on the

permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm

Res 1994;11:1358-61.

De Campos AM, Diebold Y, Carvalho EL, Sánchez A, Alonso MJ. Chitosan

nanoparticles as new ocular drug delivery systems: In vitro Stability, in

vivo fate, and cellular toxicity. Pharm Res 2004;21:803-10.

Enríquez de Salamanca A, Diebold Y, Calonge M, García-Vazquez C,

Callejo S, Vila A, et al. Chitosan nanoparticles as a potential drug delivery

system for the ocular surface: Toxicity, uptake mechanism and in vivo

tolerance. Invest Ophthalmol Vis Sci 2006;47:1416-25.

Lurui Qin Zhu Wall. Levofloxacin chitosan nanoparticles in rabbit's eyes.

Pharm Clin Res 2007;15:1.

Calvo P, Vila-Jato JL, Alonso MJ. Evaluation of cationic polymer-coated

nanocapsules as ocular drug carriers. Int J Pharm 1997;53:41-50.

Yadav KS, Sathish CS, Shivkumar HG. Preparation and evaluation of

chitosan -Poly (Acrylic acid) Hydrogels as stomach specific delivery

for amoxicillin and metronidazole. Indian J Pharm Sci 2007;69:91-5

Alonso MJ, Sanchez A. Biodegradable nanoparticles as new transmucosal drug carrier. Carrier Based Drug Delivery 2004;879:283-95.

Lehr CM, Bouwstra JA, Schacht EH, Junginger HE. Invitro evaluation of

mucoadhesive properties of chitosan and some other natural polymers.

Int J Pharm 1992;78:43-8.

Feltt O, Buri P, Gurny R. Chitosan; a unique polysaccharide for drug

delivery. Drug Dev Ind Pharm 1998;24:979-93.

Desai MP, Labhasetwar V, Amidon GL Levy RJ. Gastrointestinal uptake

of biodegradable microparticles: Effect of particle size. Pharmacol Res


Calvo P, Remunan-Lopez C, Vila-Jato JL, Alonso MJ. Novel hydrophilic

chitosan-polyethylene oxide nanoparticles as protein carriers. J Appl

Polm Sci 1997b;63:125-32.

Mosqueira VC, Legrand P, Gref R, Barratt G. In-vitro release kinetic

studies of PEG-modified nanocapsules and nanospheres loaded

with a lipophilic drug: Halofantrine base. Control Rel Bioact Mater


Mosqueira VC, Legrand P, Pinto-Alphandary H, Puisieux F, Barratt G. Poly(D, L-lactide) nanocapsules prepared by a solvent displacement process:Influence of the composition on physicochemical and structural

properties. J Pharm Sci 2000;89:614-26.

Wu Y, Yang W, Wang C, Hu J, Fu S. Chitosan nanoparticles as a

novel delivery system for ammonium glycyrrhizinate. Int J Pharm


De Campos M, Sanchez A, Alonso MJ. Chitosan nanoparticles: A new

vehicle for the improvement of the delivery of drugs to the ocular

surface. Application to cyclosporin A. Int J Pharm 2001;224:159-68.

Zhou SB, Deng XM, Li X. Investigation on a novel core-coated

microspheres protein delivery system. J Control Release 2001;75:27-36.

Lehr CM, Bouwstra JA, Schacht E, Junginger HE. In vitro evaluation of

mucoadhesive properties of chitosan and some other natural polymers.

Int J Pharm 1992;78:43-8.

Gundu ZK, O Zdemir O. Topical cyclosporine treatment of

keratoconjunctivitis sicca in secondary Sjogren's syndrome. Acta

Ophthalmol 1994;72:438-42.